Coverage
Source coverage by edition
Pick an edition to see what we cover and what we intentionally exclude.
AI
Signals and briefings for AI labs, policy, tooling, and community shifts.
Flagship sampleUnlocked today
Recent developments in agentic AI highlight the shift towards multi-agent systems and structured workflows. Researchers are exploring frameworks that enhance...
Included
- Model releases + evals
- Policy and safety narratives
- Tooling and platform shifts
Excluded
- No private roadmaps
- No behind-login scraping
Crypto
Market and social narratives surfaced from public crypto sources, evidence-linked.
Flagship sampleUnlocked today
Coverage centers on: Overnight crypto rout reverses, bitcoin rebounds to $66,300.
Included
- Market structure + regulation
- Security and exploit narratives
- Protocol + dev ecosystem
Excluded
- No paid terminals
- No private communities
CYBERSECURITY
Vulnerabilities, incidents, and threat intel signals with traceable evidence.
Flagship sampleUnlocked today
Recent security updates have been issued for PostgreSQL, Linux Kernel, and other software, addressing critical vulnerabilities with CVSS scores up to 9.8. Us...
Included
- Vulns and advisories
- Incidents + exploit narratives
- Vendor and community disclosures
Excluded
- No active scanning
- No private intel feeds
ENERGY
Energy transition signals across policy, grid, storage, and market narratives.
Flagship sampleUnlocked today
The recent developments surrounding Donut Lab's solid-state battery technology have sparked significant interest and debate. The Finnish startup has announce...
Included
- Grid + reliability narratives
- Policy + first-party data
- Storage + transition supply chain
Excluded
- No paid data terminals
- No private project databases
BIOTECH
Clinical, regulatory, and R&D narratives across biotech public sources.
Flagship sampleUnlocked today
Novo Nordisk's latest obesity treatment, CagriSema, has faced significant setbacks in clinical trials, failing to outperform Eli Lilly's Zepbound in a head-t...
Included
- Clinical + regulatory narratives
- Research + preprints
- Funding + market signals
Excluded
- No protected patient data
- No paywalled clinical DBs